Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs.
Loading...
Embargo End Date
Authors
Jones, JR
Barber, A
Le Bihan, Y-V
Weinhold, N
Ashby, C
Walker, BA
Wardell, CP
Wang, H
Kaiser, MF
Jackson, GH
Davies, FE
Chopra, R
Morgan, GJ
Pawlyn, C
Barber, A
Le Bihan, Y-V
Weinhold, N
Ashby, C
Walker, BA
Wardell, CP
Wang, H
Kaiser, MF
Jackson, GH
Davies, FE
Chopra, R
Morgan, GJ
Pawlyn, C
Document Type
Journal Article
Date
2021-10-01
Date Accepted
2021-07-27
Abstract
Citation
Leukemia, 2021, 35 (10), pp. 3017 - 3020
Source Title
Publisher
SPRINGERNATURE
ISSN
0887-6924
eISSN
1476-5551
Collections
Research Team
Myeloma Biology and Therapeutics
Target Evaluation and Molecular Therapeutics
Hit Discovery & Structural Design
Target Evaluation and Molecular Therapeutics
Hit Discovery & Structural Design